Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
Top Cited Papers
- 19 April 2005
- journal article
- clinical trial
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (5) , 279-286
- https://doi.org/10.1016/s1470-2045(05)70102-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225)Clinical Cancer Research, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferonGut, 2004
- Mutational Analysis of the Tyrosine Kinome in Colorectal CancersScience, 2003
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002